Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Story

Hadassah Conference Highlights and Honors Excellence in Research

The second annual Research Conference in memory of Dr. Ido Yatziv, former Director of Hadassah's Pediatric Intensive Care Unit (PICU), highlighted studies conducted by residents, nurses and paramedical staff.

Dr. Yatziv, who was a key figure in establishing Hadassah's new PICU, passed away suddenly in December 2011. During the Conference, the Ido Yatziv Prize for Excellence in Patient-Doctor Relations was awarded to Dr. Tomer Tzur of the Department of Plastic Surgery for his outstanding compassion and dedication to his patience as well as professional distinction.

The Pediatric Division Award for Excellence in Research was awarded to Dr. Polina Stepensky, Senior Physician in the Pediatric Hemato-Oncology Department and Coordinator for pediatric bone marrow transplantations. Her research includes clinical trials of bone marrow transplantation among children and the development of new treatment methods; genetic diagnosis and characterization of immunological diseases; and characterization of the immunological function of congenital diseases of the immune system.

The Prize for Excellence in Nursing was awarded to Galit Copenhagen of the Pediatric Surgery Department. Recognized as a leader by her peers and managers, Ms. Copenhagen is respected for her devotion to raising the bar for professionalism in her department. Additionally, she has helped to promote the department's pain management project.

Among the topics discussed during the Conference were: nutrition among children, developing new diagnostic methods for treating children, the issue of pain management, and basic and clinical research dealing with common chronic and complex diseases in children.

Date: 6/3/2013

More hMedicine Stories

Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America